Table 3.

Multivariate analysis for systolic function population

Risk factor	Model 1 OR (95% CI)	P value	Model 2 (95% CI)	P value	Model 3 (95% CI)	P value
Current smoker	0.19 (0.04–0.88)	0.034	0.19 (0.04–0.88)	0.034	0.19 (0.04–0.89)	0.026
ACE inhibitor at discharge	3.15 (1.04–9.51)	0.042	3.15 (1.04–9.51)	0.042	3.65 (1.17–11.36)	0.035
Peak hsTnT > 610 (ng/L)	3.30 (1.28–8.54)	0.014	3.30 (1.28–8.54)	0.014	3.14 (1.24–8.00)	0.016
MMP-8 (ng/mL)	3.43 (0.32–36.68)	0.308
Factor 1 score			0.80 (0.53–1.22)	0.307
Cluster One assignment					2.74 (1.04–7.23)	0.042

Model 1 = Current smoking status, prescription of ACE inhibitor at discharge, hs-TnT > median 610 ng/L and MMP-8 concentrations; Model 2 = Current smoking status, prescription of ACE inhibitor at discharge, hs-TnT > median 610 ng/L and Factor 1 score; Model 3 = Current smoking status, prescription of ACE inhibitor at discharge, hs-TnT > median 610 ng/L and Cluster One assignment

Abbreviations: ACE angiotensin-converting-enzyme; hs high-sensitivity; MMP-8 matrix metalloproteinase-8; hsTnT high-sensitivity Troponin T

Significant p-values are bolded (p < 0.05)